Literature DB >> 8053162

Herpes simplex virus replicative concatemers contain L components in inverted orientation.

D Bataille1, A Epstein.   

Abstract

The structure of herpes simplex virus (HSV-1) replicative DNA was studied employing pulse-field gel electrophoresis to allow separation and direct visualization of large size virus DNA fragments. Accumulation of HSV-1 DNA that fails to enter the gel was detected from 6 hr postinfection. This corresponds, at least in part, to high molecular weight replicative intermediates. Analysis of this DNA employing restriction enzymes SpeI and AseI, which cut only once and twice respectively in the HSV-1 genome, revealed that these intermediates are concatemeric and contain adjacent genomes with L components in different orientations. Adjacent genomes with L components in the same orientation or with L components in inverted orientations were found in similar amounts, suggesting that inversions occur frequently. Our results suggest that inversions of L components are generated by a quite efficient mechanism, perhaps during replication. Observations made in this work could be explained by rolling circle-based models of replication of HSV-1 genomes, with replication starting at the different origins and/or combined with strand transfer at inverted repeats.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8053162     DOI: 10.1006/viro.1994.1498

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  29 in total

1.  Machinery to support genome segment inversion exists in a herpesvirus which does not naturally contain invertible elements.

Authors:  M A McVoy; D Ramnarain
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  The ends on herpesvirus DNA replicative concatemers contain pac2 cis cleavage/packaging elements and their formation is controlled by terminal cis sequences.

Authors:  M A McVoy; D E Nixon; J K Hur; S P Adler
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Isomerization of a uniquely designed amplicon during herpes simplex virus-mediated replication.

Authors:  H Wang; X Fu; X Zhang
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

4.  High-frequency intermolecular homologous recombination during herpes simplex virus-mediated plasmid DNA replication.

Authors:  Xinping Fu; Hua Wang; Xiaoliu Zhang
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

5.  Intracellular Cre-mediated deletion of the unique packaging signal carried by a herpes simplex virus type 1 recombinant and its relationship to the cleavage-packaging process.

Authors:  C Logvinoff; A L Epstein
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

6.  Equimolar generation of the four possible arrangements of adjacent L components in herpes simplex virus type 1 replicative intermediates.

Authors:  D Bataille; A L Epstein
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

7.  Herpes simplex virus type 1 alkaline nuclease is required for efficient processing of viral DNA replication intermediates.

Authors:  R Martinez; R T Sarisky; P C Weber; S K Weller
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

8.  The impact of genome length on replication and genome stability of the herpesvirus guinea pig cytomegalovirus.

Authors:  Xiaohong Cui; Alistair McGregor; Mark R Schleiss; Michael A McVoy
Journal:  Virology       Date:  2009-01-26       Impact factor: 3.616

9.  Impact of 2-bromo-5,6-dichloro-1-beta-D-ribofuranosyl benzimidazole riboside and inhibitors of DNA, RNA, and protein synthesis on human cytomegalovirus genome maturation.

Authors:  Michael A McVoy; Daniel E Nixon
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

10.  Recruitment of cellular recombination and repair proteins to sites of herpes simplex virus type 1 DNA replication is dependent on the composition of viral proteins within prereplicative sites and correlates with the induction of the DNA damage response.

Authors:  Dianna E Wilkinson; Sandra K Weller
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.